Skeletal and hematological anomalies in HYAL2‐deficient mice: a second type of mucopolysaccharidosis IX?
- 18 August 2008
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 22 (12), 4316-4326
- https://doi.org/10.1096/fj.08-111997
Abstract
The metabolism of hyaluronan (HA) relies on HA synthases and hyaluronidases, among which hyaluronidase-1 (HYAL1) and -2 (HYAL2) have been proposed as key actors. Congenital HYAL1 deficiency leads to mucopolysaccharidosis IX (MPS IX), a rare lysosomal storage disorder characterized by joint abnormalities. Knowledge of HYAL2 is limited. This protein displays weak in vitro hyaluronidase activity and acts as a receptor for oncogenic ovine retroviruses. We have generated HYAL2-deficient mice through a conditional Cre-lox system. Hyal2−/− mice are viable and fertile. They exhibit localized congenital defects in frontonasal and vertebral bone formation and suffer from mild thrombocytopenia and chronic, possibly intravascular, hemolysis. In addition, Hyal2−/− mice display 10-fold increases in plasma levels of HA and 2-fold increases in plasma hyaluronidase activity. Globally, there is no HA accumulation in tissues, including bones, but liver sinusoidal cells seem overloaded with undigested HA. Taken together, these elements demonstrate for the first time that murine HYAL2 has a physiological activity in vivo that is relevant for craniovertebral bone formation, maintenance of plasma HA concentrations, and erythrocyte and platelet homeostasis. In addition, the viability of HYAL2-deficient mice raises the possibility that a similar defect, defining a new MPS disorder, exists in humans.—Jadin, L., Wu, X., Ding, H., Frost, G. I., Onclinx, C., Triggs-Raine, B., Flamion, B. Skeletal and hematological anomalies in HYAL2-deficient mice: a second type of mucopolysaccharidosis IX?Keywords
This publication has 39 references indexed in Scilit:
- A mouse model of human mucopolysaccharidosis IX exhibits osteoarthritisHuman Molecular Genetics, 2008
- Ability of Hyaluronidase 2 To Degrade Extracellular Hyaluronan Is Not Required for Its Function as a Receptor for Jaagsiekte Sheep RetrovirusJournal of Virology, 2007
- Impaired posterior frontal sutural fusion in the biglycan/decorin double deficient miceBone, 2006
- Sperm dysfunction in the Rb(6.16)- and Rb(6.15)-bearing mice revisited: Involvement ofHyalp1 andHyal5Molecular Reproduction and Development, 2005
- Cell biology and pathology of liver sinusoidal endothelial cellsMedical Molecular Morphology, 2004
- Endocytic Function, Glycosaminoglycan Specificity, and Antibody Sensitivity of the Recombinant Human 190-kDa Hyaluronan Receptor for Endocytosis (HARE)Published by Elsevier BV ,2004
- Enhanced activity of serum and urinary hyaluronidases in streptozotocin-induced diabetic Wistar and GK ratsGlycobiology, 2003
- A Blocking Antibody to the Hyaluronan Receptor for Endocytosis (HARE) Inhibits Hyaluronan Clearance by Perfused LiverPublished by Elsevier BV ,2003
- Purification, Cloning, and Expression of Human Plasma HyaluronidaseBiochemical and Biophysical Research Communications, 1997
- Serum Hyaluronan as a Disease MarkerAnnals of Medicine, 1996